Image Courtesy of RenovoRx El Camino Hospital is conducting a dose-escalation safety study using RenovoRx’s Los Altos-manufactured catheter, RenovoCath.
El Camino Hospital in Mountain View enrolled its first patient earlier this month in a new safety study of a catheter that delivers targeted chemotherapy for pancreatic cancer.
RenovoCath – manufactured in Los Altos by RenovoRx – brings fluids to targeted sites in the peripheral vascular system. The dose-escalation safety study evaluates the delivery of the anticancer drug Gemcitabine, directly infused into the arteries that supply blood flow to the area of the pancreatic tumor. The therapy is being tested in patients with cancer that cannot be surgically removed from the pancreas.